28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy

Key Takeaways Explain This Topic AI

Acute peripheral facial nerve palsy (Bell's palsy) causes flaccid lower motor neuron paralysis of both upper and lower facial muscles (inability to wrinkle forehead, lagophthalmos, flattened nasolabial fold, drooping mouth corner), distinguishing it from central upper motor neuron lesions (ischemic stroke), where bilateral cortical motor innervation preserves forehead wrinkling.

Oral corticosteroids (prednisone 60-80 mg daily for 7 days followed by a 5-day taper) must be initiated within 72 hours of symptom onset to maximize complete facial nerve recovery; rigorous ocular protection (preservative-free artificial tears hourly awake, thick lubricating ointment at bedtime, and eyelid taping) is essential to prevent exposure keratitis and permanent corneal ulceration.

Ramsay Hunt syndrome (herpes zoster oticus) is a varicella-zoster virus reactivation in the geniculate ganglion presenting as acute peripheral facial palsy, severe otalgia, and painful vesicular eruptions within the external auditory canal or concha, requiring prompt dual therapy with high-dose corticosteroids and oral valacyclovir 1000 mg three times daily.

Carpal tunnel syndrome results from median nerve compression beneath the transverse carpal ligament, presenting with nocturnal acroparesthesias in the radial three-and-a-half digits with sensory sparing of the thenar eminence; Durkan's carpal compression test exhibits the highest diagnostic sensitivity and specificity, and nocturnal neutral-wrist splinting is the evidence-based first-line conservative intervention.

Lumbosacral and cervical radiculopathies produce distinct dermatomal and myotomal deficits: C6 affects the biceps/brachioradialis reflex and thumb/index sensation, C7 compromises the triceps reflex and middle finger, L4 diminishes the patellar reflex and knee extension, L5 impairs great toe extension without reflex change, and S1 suppresses the Achilles reflex; red flags including saddle anesthesia, progressive motor paresis, or bowel/bladder dysfunction mandate emergent MRI to exclude cauda equina syndrome.

Last updated: September 2026

Bell's Palsy: Clinical Neuroanatomy, Diagnostic Assessment & Management

Acute peripheral facial nerve palsy (Bell's palsy) is the most frequent cause of acute spontaneous unilateral facial paralysis, accounting for approximately 60% to 75% of all peripheral facial palsy presentations. Understanding its underlying neuroanatomy and pathophysiological mechanics is critical for rapid bedside differentiation from life-threatening central vascular emergencies.

Neuroanatomy & Pathophysiology

The facial nerve (cranial nerve VII) originates in the caudal pontine tegmentum and traverses the cerebellopontine angle alongside cranial nerve VIII. It enters the internal acoustic meatus and proceeds through the narrow, tortuous bony fallopian canal within the petrous temporal bone. The fallopian canal contains the labyrinthine segment , which represents the narrowest constriction of the entire facial nerve course (often <0.7 mm in diameter).

Underlying reactivation of latent herpes simplex virus type 1 (HSV-1) —or less commonly, other viral pathogens such as Epstein-Barr virus (EBV) or cytomegalovirus (CMV)—triggers an intense local inflammatory response. Due to the rigid, non-distensible bony walls of the labyrinthine segment, inflammatory edema produces progressive intraneural vascular compression, secondary microvascular ischemia, and conduction block (neuropraxia) or mechanical axonal disruption.

Beyond supplying somatic motor fibers to all muscles of facial expression, the facial nerve carries distinct functional fiber systems whose impairment localized within the fallopian canal produces accompanying clinical deficits:

Branchial Somatic Motor Fibers : Innervate the frontalis, orbicularis oculi, buccinator, orbicularis oris, platysma, and the stapedius muscle in the middle ear. Paralysis of the stapedius muscle abolishes the acoustic stapedial reflex, producing painful acoustic hypersensitivity ( hyperacusis ), where ordinary sounds are perceived as uncomfortably loud.

Special Visceral Sensory (Taste) Fibers : Carried via the chorda tympani nerve to innervate taste buds across the anterior two-thirds of the tongue . Patients frequently report dysgeusia, hypogeusia, or a metallic gustatory sensation.

General Visceral Parasympathetic Fibers : Carried via the greater petrosal nerve to the lacrimal gland (regulating tearing) and via the chorda tympani to the submandibular and sublingual salivary glands. Interruption can result in decreased ipsilateral tear production ( dry eye ); paradoxically, patients often report epiphora (overflow tearing) due to severe orbicularis oculi weakness that abolishes normal blinking and prevents mechanical pumping of tears into the nasolacrimal duct.

The Forehead-Sparing Rule: UMN vs. LMN Facial Weakness

The most pivotal bedside neurological discrimination is differentiating a peripheral lower motor neuron (LMN) facial palsy (e.g., Bell's palsy) from a central upper motor neuron (UMN) lesion (e.g., ischemic stroke involving the motor cortex or corticobulbar tract). CENTRAL (UMN) vs. PERIPHERAL (LMN) FACIAL INNERVATION

• Contralateral Motor Cortex Ipsilateral Motor Cortex
• │ │ │ │
• │ │ │ │
• ▼ ▼ ▼ ▼
• ┌───────────────┐ ┌───────────────┐ ┌───────────────┐ ┌───────────────┐
• │ Upper Nucleus │ │ Lower Nucleus │ │ Upper Nucleus │ │ Lower Nucleus │
• │ (Forehead/Eye)│ │ (Mouth/Cheek) │ │ (Forehead/Eye)│ │ (Mouth/Cheek) │
• └───────┬───────┘ └───────┬───────┘ └───────┬───────┘ └───────┬───────┘
• │ Bilateral │ Contralateral │ Bilateral │ Contralateral
• │ Innervation │ Innervation │ Innervation │ Innervation
• ▼ ▼ ▼ ▼
• =========================================================================
• UMN Lesion (Stroke): Forehead SPARED LMN Lesion (Bell's): COMPLETE HEMIFACIAL
• Contralateral lower face droop - Inability to wrinkle forehead
• Normal forehead wrinkling & eye closure - Inability to close eye (lagophthalmos)
• Preserved eyebrow elevation - Lower facial droop & smile asymmetry
• Critical Anatomical Rule

The facial motor nucleus in the caudal pons is anatomically split into an upper subnucleus (which supplies the frontalis and orbicularis oculi muscles) and a lower subnucleus (which supplies the muscles of the lower face, including the buccinator, orbicularis oris, and platysma).

The upper subnucleus receives bilateral corticobulbar motor input from both the left and right cerebral motor cortices.

In contrast, the lower subnucleus receives strictly contralateral corticobulbar motor input from the opposite motor cortex.

Central UMN Lesion (Stroke / TIA / Intracranial Mass) : An ischemic cortical infarction spares the ipsilateral motor projections to the upper subnucleus. Consequently, forehead wrinkling and eyebrow elevation are fully preserved , while the contralateral lower face exhibits marked weakness (flattened nasolabial fold, drooping oral commissure).

Peripheral LMN Lesion (Bell's Palsy / Facial Nerve Compression) : Any lesion at or distal to the facial motor nucleus in the pons compromises all axonal projections to that half of the face. Therefore, there is flaccid weakness involving BOTH the upper and lower face : the patient cannot wrinkle the forehead, cannot tightly close the eye ( lagophthalmos ), exhibits an upward rolling of the eye upon attempted closure ( Bell's phenomenon ), and displays a flattened nasolabial fold with unilateral oral droop.

Clinical Staging: The House-Brackmann Facial Nerve Grading System

The severity and recovery of facial nerve dysfunction are universally quantified using the House-Brackmann (HB) Facial Nerve Grading System :

Grade Clinical Description Forehead Motion Eye Closure Mouth / Oral Symmetry Spontaneous Prognosis

Grade I (Normal) Normal facial motor function across all branches Normal Complete, effortless Normal tone and movement 100% full baseline function

Grade II (Mild) Slight weakness on close inspection; normal resting symmetry Moderate to good function Complete with minimal effort Slight asymmetry on maximal smile Excellent (~95-100% full recovery)

Grade III (Moderate) Obvious non-disfiguring asymmetry; normal symmetry at rest Slight to moderate motion Complete with maximal effort Noticeable weakness with maximal effort Very good (~85-90% recovery)

Grade IV (Moderately Severe) Disfiguring asymmetry; normal resting tone None (paralyzed) Incomplete eye closure Obvious asymmetry with effort Guarded (~50-70% recovery; risk synkinesis)

Grade V (Severe) Barely perceptible motion; resting facial asymmetry None (paralyzed) Incomplete eye closure Barely perceptible motion on effort Poor without early intervention (~20-40%)

Grade VI (Total) Complete flaccid paralysis; no movement anywhere None (paralyzed) Completely open Immobile Unfavorable without intervention

Ramsay Hunt Syndrome (Herpes Zoster Oticus)

Ramsay Hunt syndrome represents the second most common cause of acute atraumatic peripheral facial paralysis (accounting for ~10-15% of cases), provoked by reactivation of latent varicella-zoster virus (VZV) within the geniculate ganglion of cranial nerve VII.

Diagnostic Triad

Peripheral Lower Motor Neuron Facial Palsy : Indistinguishable on motor testing from severe Bell's palsy (House-Brackmann Grade IV-VI).

Severe, Debilitating Otalgia : Intense burning, throbbing, or lancinating deep ear and mastoid pain, typically preceding facial weakness by 24 to 72 hours.

Vesicular Cutaneous Eruption : Painful, erythematous herpetic vesicles located on the pinna, conchal bowl, external auditory canal, tragus, or tympanic membrane. In some cases, vesicles appear on the anterior two-thirds of the tongue or soft palate.

Clinical Red Flag / Cranial Polyneuropathy : Due to intimate anatomical proximity within the internal acoustic meatus, VZV frequently spreads to involve cranial nerve VIII , causing severe sensorineural hearing loss, tinnitus, and acute rotational vertigo.

Treatment : Ramsay Hunt carries a significantly worse prognosis than Bell's palsy (<50% complete recovery if untreated). Mandatory therapy requires immediate initiation of high-dose oral corticosteroids (Prednisone 60-80 mg daily) combined with high-dose oral antivirals (Valacyclovir 1,000 mg TID or Famciclovir 500 mg TID for 7 to 10 days) .

Evidence-Based Medical Management of Bell's Palsy BELL'S PALSY TREATMENT PROTOCOL

• Acute Onset Unilateral LMN Facial Weakness Peaking <=72 Hours
• │
• ▼
• Examine Concha, EAC, Oral Cavity & Cranial Nerves
• │
• ┌────────────────────┴────────────────────┐
• ▼ ▼
• Vesicles Present (Ramsay Hunt) Normal Skin & Mucosa (Bell's)
• Oral Prednisone 60-80 mg daily Oral Prednisone 60-80 mg daily
• PLUS PLUS
• Oral Valacyclovir 1000 mg TID Optional Valacyclovir (Severe HB IV-VI)
• (Both for 7-10 days) Rigorous Eye Protection Protocol
• Corticosteroid Pharmacotherapy

First-Line Standard of Care : Extensive Cochrane systematic reviews and landmark randomized trials (including the Sullivan 2007 NEJM and Engström 2008 Lancet trials) confirm that oral corticosteroids initiated within 72 hours of symptom onset significantly increase complete recovery rates (from ~65-70% to >85-90%) and reduce long-term sequelae such as contracture and autonomic synkinesis (e.g., crocodile tears syndrome / Bogorad syndrome).

Standard Dosing Regimen : Prednisone 60 to 80 mg PO daily for 7 days , followed by a 5-day taper (e.g., 50 mg, 40 mg, 30 mg, 20 mg, 10 mg daily), for a total treatment duration of 10 to 12 days.

Time Sensitivity : Corticosteroids started beyond 72 hours show minimal to no statistically significant therapeutic benefit compared to placebo, as neural edema and secondary axonal loss have already evolved.

Role of Antiviral Therapy

Adding an oral antiviral agent (Valacyclovir 1,000 mg PO TID or Acyclovir 400 mg PO five times daily for 7 days) to corticosteroids has not shown statistically significant benefit in mild-to-moderate Bell's palsy (House-Brackmann II-III).

However, in patients presenting with severe facial paralysis (House-Brackmann IV, V, or VI) , high-quality guidelines (AAO-HNS 2013, Canadian Practice Guidelines) suggest offering combined therapy (Prednisone + Valacyclovir), given modest trends toward improved functional recovery and minimal adverse drug events. Antivirals as monotherapy without steroids are strictly ineffective and must not be used.

Mandatory Eye Protection Protocol (Preventing Corneal Blindness)

Incomplete eyelid closure ( lagophthalmos ) combined with impaired lacrimal gland output eliminates the protective tear film. Unopposed environmental exposure rapidly triggers exposure keratitis , secondary corneal desiccation, epithelial defects, bacterial ulceration, and permanent corneal scarring:

Daytime Lubrication : Preservative-free lubricating artificial tears (hypromellose or carboxymethylcellulose) instilled every 1 to 2 hours while awake .

Nighttime Protection : Application of high-viscosity ophthalmic lubricating ointment (white petrolatum / mineral oil) inside the lower conjunctival sac immediately before sleep.

Bedtime Taping / Moisture Chamber : Careful mechanical taping of the upper eyelid closed using hypoallergenic paper tape, or wearing a protective transparent moisture chamber (bubble eye shield) overnight.

Urgent Ophthalmology Referral : Indicated immediately if the patient develops eye pain, ocular erythema, foreign body sensation, or decreased visual acuity.

Diagnostic Red Flags & Imaging Indications

Bell's palsy is a clinical diagnosis. Routine laboratory testing and head CT/MRI are NOT indicated for acute typical presentations. However, contrast-enhanced Brain MRI with internal auditory canal (IAC) protocol is mandatory if:

• Weakness progresses beyond 3 weeks from onset;
• No signs of facial motor recovery appear after 3 to 4 months;
• Other cranial neuropathies are present (excluding hyperacusis or chorda tympani taste loss);

Isolated, selective branch weakness occurs (e.g., isolated marginal mandibular palsy, strongly suggesting a parotid gland neoplasm);

Recurrent unilateral or alternating bilateral facial paralysis (concerning for sarcoidosis [Heerfordt syndrome], Lyme disease, lymphoma, or Melkersson-Rosenthal syndrome).

Carpal Tunnel Syndrome (CTS): Diagnosis & Stepwise Management

Carpal tunnel syndrome (CTS) is the most prevalent compressive entrapment neuropathy, affecting 3% to 6% of the general adult population. It results from elevated interstitial pressure within the rigid, fibro-osseous carpal canal, producing mechanical ischemia and demyelination of the median nerve .

Anatomy of the Carpal Tunnel

The carpal tunnel is bound deeply by the carpal bones (sulcus carpi) and superficially by the dense transverse carpal ligament (flexor retinaculum) . The tunnel accommodates 10 rigid anatomical structures :

• 4 tendons of the flexor digitorum superficialis (FDS);
• 4 tendons of the flexor digitorum profundus (FDP);
• 1 tendon of the flexor pollicis longus (FPL);

The median nerve .

Critical Anatomical Nuance : The palmar cutaneous branch of the median nerve arises approximately 5 to 7 cm proximal to the wrist crease and courses superficial to the transverse carpal ligament . Consequently, sensation over the thenar eminence is anatomically spared in isolated carpal tunnel syndrome . Loss of thenar sensation indicates a proximal lesion at the forearm level (pronator teres syndrome) or cervical radiculopathy (C6 root impingement). ANATOMICAL DISTRIBUTION OF CARPAL TUNNEL

[Volan Aspect of Right Hand]

• Digit I Digit II Digit III Digit IV Digit V
• (Thumb) (Index) (Middle) (Ring) (Little)
• ┌───────┐ ┌───────┐ ┌───────┐ ┌───┬───┐ ┌───────┐
• │Median │ │Median │ │Median │ │Med│Uln│ │ Ulnar │
• │ Nerve │ │ Nerve │ │ Nerve │ │Nrv│Nrv│ │ Nerve │
• └───────┘ └───────┘ └───────┘ └───┴───┘ └───────┘
• \ │ / / │
• \ │ / / │
• ▼ ▼ ▼ ▼ │
• ┌───────────────────────────────┐ │
• │ MEDIAN NERVE PARESTHESIAS │ │
• └───────────────┬───────────────┘ │
• │ ▼
• ┌───────────────┴───────────────┐ ┌─────────────────┐
• │ Thenar Eminence Sensation │ │ Entire Digit V │
• │ SPARED (Palmar Cutaneous Br.) │ │ Completely │
• └───────────────────────────────┘ │ NORMAL │
• └─────────────────┘
• Clinical Presentation

Nocturnal Acroparesthesias : Tingling, burning, numbness, and aching pain localized to the palmar surface of the thumb, index finger, middle finger, and the radial half of the ring finger. Symptoms characteristically wake the patient from sleep due to prolonged wrist flexion and recumbent interstitial fluid redistribution.

The 'Flick Sign' : Relief of paresthesias following vigorous shaking, flicking, or massaging of the affected wrist/hand (sensitivity ~93%, specificity ~96%).

Motor Involvement : With prolonged axonal injury, patients develop weakness of the abductor pollicis brevis (APB) muscle (tested by resisting thumb abduction perpendicular to the palm) and progressive flattening / atrophy of the thenar eminence .

Provocative Physical Examination Maneuvers

Provocative Test Clinical Technique Positive Result Diagnostic Accuracy

Durkan Carpal Compression Test Examiner applies direct, continuous bilateral thumb pressure over the carpal tunnel (median nerve) for 30 seconds Reproduction of numbness, tingling, or burning in median nerve distribution Highest accuracy : Sensitivity ~87-89%, Specificity ~90%

Phalen Maneuver Patient holds wrists in complete, unforced maximal flexion (dorsa of hands apposed) for 60 seconds Reproduction of paresthesias along digits 1 through 3 within 60 seconds Sensitivity ~68-73%, Specificity ~73-86%

Tinel Sign Examiner lightly taps with a reflex hammer or index finger along the median nerve at the volar wrist crease Elicits electric shock-like paresthesias shooting into the thumb, index, or middle finger Sensitivity ~50-60%, Specificity ~77-87%

Thumb Abduction Strength Patient attempts to abduct the thumb vertically upward against downward resistance from the examiner Weakness of the abductor pollicis brevis (APB) indicates significant motor axonal loss Specific for motor neuropathy; late finding

Stepwise Management Algorithm

First-Line Conservative Therapy : Nocturnal Neutral-Wrist Splinting .

Rigid splint holding the wrist in neutral position (0° to 5° of extension) , worn every night for at least 6 to 8 weeks.

Intracarpal tunnel pressure is lowest at neutral (averaging 5-10 mmHg); flexion or extension elevates pressure beyond 30-50 mmHg, precipitating capillary collapse. Day wear is added if symptoms occur during daytime work activities.

Ergonomic workstation modification (keyboard wrist rests, avoiding repetitive power gripping).

Second-Line Pharmacotherapy & Injections :

Oral NSAIDs provide minimal long-term benefit for nerve compression itself but help coexisting flexor tenosynovitis.

Ultrasound-Guided Carpal Tunnel Corticosteroid Injection : 20 to 40 mg of triamcinolone acetonide or methylprednisolone acetate injected deep to the transverse carpal ligament into the flexor tenosynovial sheath. Provides substantial symptomatic relief lasting 1 to 3 months, functioning as an effective therapeutic bridge or non-surgical alternative.

Electrodiagnostic Studies (EMG / Nerve Conduction Studies) :

Not required for initial mild clinical cases. Indicated when the clinical diagnosis is equivocal, if symptoms fail conservative therapy, if motor weakness/atrophy is detected, or for pre-operative confirmation.

Findings: Prolonged sensory and motor distal latencies across the wrist, reduced sensory nerve action potential (SNAP) amplitude, and fibrillation potentials on needle EMG (denervation).

Surgical Carpal Tunnel Release (Open or Endoscopic) :

Complete division of the transverse carpal ligament decompresses the carpal tunnel.

Absolute Indications : Persistent or progressive symptoms despite 3 to 6 months of conservative therapy; severe sensory loss / two-point discrimination >6 mm; electrodiagnostic evidence of axonal loss; or objective thenar muscle atrophy / APB motor weakness .

Cervical and Lumbar Radiculopathy: Neuro-Localization & Red Flags

Radiculopathy is an acute or subacute condition caused by mechanical compression or biochemical inflammation of a spinal nerve root, resulting in pain, paresthesias, sensory loss, motor weakness, and hyporeflexia in the corresponding myotome and dermatome.

Etiology: Herniated Disc vs. Spondylosis

Younger Patients (<50 years) : Herniated nucleus pulposus through a torn annulus fibrosus, causing chemical irritation and physical displacement of the traversing or exiting nerve root.

Older Patients (>50 years) : Degenerative spondylosis, including osteophyte formation, facet joint hypertrophy, ligamentum flavum thickening, and degenerative neuroforaminal stenosis.

Cervical Radiculopathy Localization

Cervical nerve roots exit above their corresponding numbered vertebrae (e.g., the C6 root exits between C5 and C6), except for the C8 root, which exits between C7 and T1. CERVICAL RADICULOPATHY LOCALIZATION

• ROOT DERMATOME MOTOR TESTING REFLEX
• ───────────────────────────────────────────────────────────────────
• C5 Lateral shoulder Shoulder abduction (Deltoid) Biceps reflex
• (epaulet area) Elbow flexion (Biceps)
• C6 Lateral forearm, Elbow flexion (Brachiorad.) Brachioradialis &
• Thumb & Index finger Wrist extension (ECRL/ECRB) Biceps reflex
• C7* Middle finger Elbow extension (Triceps) Triceps reflex
• Wrist flexion (FCR)
• C8 Medial forearm, Finger flexion (FDP/FDS) No reliable reflex
• Ring & Little finger Hand intrinsics (Interossei)
• ───────────────────────────────────────────────────────────────────

*C7 is the MOST COMMON cervical radiculopathy (~60% of all cases).

Spurling Test (Neck Compression Test) : Patient extends the neck, laterally rotates the head toward the symptomatic side, while the examiner applies gentle axial downward force on the vertex. A positive test reproduces sharp, radiating radicular pain down the ipsilateral arm (high specificity >90%, moderate sensitivity ~50%).

Shoulder Abduction (Bakody) Relief Sign : Patient lifts the symptomatic arm and rests the hand on top of the head. Relief of radicular pain indicates cervical root pathology (reduces tension across the lower cervical roots).

Lumbar Radiculopathy (Sciatica) Localization

In the lumbar spine, nerve roots exit below their numbered vertebrae (e.g., L4 root exits beneath the L4 pedicle). Posterolateral disc herniations typically compress the traversing nerve root (e.g., an L4-L5 herniation compresses the traversing L5 root; an L5-S1 herniation compresses the traversing S1 root). LUMBAR RADICULOPATHY LOCALIZATION

• ROOT DERMATOME MOTOR / FUNCTIONAL GAIT REFLEX
• ───────────────────────────────────────────────────────────────────
• L4 Anteromedial thigh, Knee extension (Quadriceps) Patellar reflex
• Knee & Medial malleolus Squat and rise difficulty (Diminished/absent)
• L5* Anterolateral leg, Great toe extension (EHL) NONE
• Foot dorsum & Big toe Heel walking difficulty (No reliable reflex)
• S1* Posterior calf, Plantarflexion (Gastroc.) Achilles reflex
• Sole & Lateral foot Toe walking difficulty (Diminished/absent)
• ───────────────────────────────────────────────────────────────────

*L5 and S1 represent >95% of all lumbar disc herniations.

Straight Leg Raise (SLR / Lasègue Test) : Patient supine; examiner passively elevates the symptomatic leg with the knee fully extended. A positive test reproduces sharp, shooting radicular pain radiating below the knee between 30° and 70° of elevation (Sensitivity ~91%, Specificity ~40%).

Crossed Straight Leg Raise (Well Leg Raise) : Passive elevation of the asymptomatic contralateral leg reproduces radicular pain down the symptomatic leg. Indicates severe nerve root impingement or large central/paracentral disc herniation ( Specificity >90% , Sensitivity ~30%).

Conservative Management & Urgent Surgical Indications

Uncomplicated Radiculopathy : 6 to 8 weeks of active conservative therapy without routine imaging: oral NSAIDs (first-line), short course oral gabapentinoids, early structured physical therapy, and strict avoidance of prolonged bed rest.

EMERGENCY NEUROSURGICAL RED FLAGS (Mandatory STAT MRI of the Spine) :

Cauda Equina Syndrome (L2-S5 Root Compression) :

• Bilateral lower extremity radicular pain and progressive motor weakness;
• Saddle anesthesia : Loss of sensation over the perineum, perianal region, buttocks, and inner thighs;

Urinary retention or overflow incontinence : Elevated post-void residual (PVR >200 mL) due to detrusor arreflexia;

Fecal incontinence and loss of anal sphincter resting tone on digital rectal examination.

Action : STAT emergency MRI and decompressive laminectomy within 24 to 48 hours to prevent permanent bladder, bowel, and sexual paralysis.

Rapidly Progressive Motor Deficit : E.g., acute foot drop (severe L5 motor loss) or rapidly advancing quadriceps weakness.

Spinal Epidural Abscess or Hematoma : Back pain, fever, focal neurologic deficits, elevated inflammatory markers (ESR/CRP), history of injection drug use, indwelling catheter, or epidural anesthesia.

Loading diagram... Clinical Algorithm for Acute Cranial, Median & Radicular Neuropathies